AI Summary
✦ ClarthaValuation Metrics
Trading 83.9% above historical median. Valuation is rising — currently in the strongly overvalued zone (z-score: +2.33). Confidence: 68%.
Live forward EPS implies next-12-month EPS of ₹49.77. Applying the stock's normalized valuation corridor produces a fair range of ₹997.89 to ₹1,443.33, with base value near ₹1,282.57 (-9.8% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹49.77
Forward P/E
28.6x
Base Fair Value
₹1,282.57
Fair Range
₹997.89 - ₹1,443.33
Upside To Base
-9.8%
Estimate Source
Live forward EPS
Growth Estimate
+43.5%
5Y Average
28.51
Current
47.39
Overvalued
29.00
Undervalued
20.05
5Y Average
20.04
Current
35.29
Overvalued
20.91
Undervalued
14.38
5Y Average
5.47
Current
9.63
Overvalued
5.70
Undervalued
3.92
Peers & Comparison
Sector: Health Care · Theme: Pharmaceuticals
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
AKUMS DRUGS AND PHARMA L AKUMSPharmaceuticals | +9.6% | 5.9% | 43.8x Undervalued | -34% vs avg | +45.4% |
BLUE JET HEALTHCARE LTD BLUEJETPharmaceuticals | -17.4% | 26.5% | 43.7x Undervalued | -34% vs avg | -25.8% |
CONCORD BIOTECH LIMITED CONCORDBIOPharmaceuticals | +26.2% | 24.8% | 48.8x Undervalued | -27% vs avg | -14.9% |
ASTRAZENECA PHARMA IND LT ASTRAZENPharmaceuticals | +20.4% | 8.2% | 107.4x Premium | +62% vs avg | -6.9% |
CAPLIN POINT LAB LTD. CAPLIPOINTPharmaceuticals | +19.0% | 29.3% | 31.2x Undervalued | -53% vs avg | +22.1% |
ALIVUS LIFE SCIENCES LTD ALIVUSPharmaceuticals | +6.4% | 23.3% | 28.0x Undervalued | -58% vs avg | +43.4% |
COHANCE LIFESCIENCES LTD COHANCEPharmaceuticals | -23.1% | 5.0% | 162.0x Premium | +144% vs avg | -52.7% |
SENORES PHARMACEUTICALS L trades at a discount (50.2x vs peer avg 66.4x), suggesting potential undervaluation relative to the Pharmaceuticals cohort. Peers include AKUMS DRUGS AND PHARMA L, BLUE JET HEALTHCARE LTD, CONCORD BIOTECH LIMITED — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Financial chart data is not available for this company right now.
Results
Income statement data not available.
All values in ₹ Crores unless otherwise stated. Source: Company filings.